(DecisionDx ®-Melanoma, TissueCypher ®) increased 37% over 2024. Exceeded 2025 guidance with full-year revenue of $344 milli ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results